Global Search | Novartis

Hide Filters

Showing 2694 results

Media Library / Mar 01, 2024

Refrigeration room at a Novartis radioligand therapy (RLT) manufacturing facility
Media Library / Mar 01, 2024

Specialized equipment for the manufacture of radioligand therapy (RLT)
Media Library / Mar 01, 2024

Quality control for environmental monitoring in radioligand therapy (RLT) manufacturing
Press Release / Mar 05, 2024

Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting

Shareholders approve 27th consecutive dividend increase to CHF 3.30 (+3.1%) per share for 2023; representing a 3.7% yield1 and approximately 58% payout of free cash flowShareholders confirm Joerg…
Press Release / Mar 05, 2024

Les actionnaires de Novartis approuvent toutes les résolutions proposées par le Conseil d’administration lors de l’Assemblée générale ordinaire

Les actionnaires approuvent la 27e augmentation consécutive du dividende qui passe à CHF 3,30 (+3,1%) par action pour 2023 ; représentant un rendement de 3,7%1 et une distribution du…
Press Release / Mar 04, 2024

Novartis presents new data on safety and efficacy of Zolgensma, including maintained and improved motor milestones in older and heavier children with SMA

The SMART study supplements a growing body of evidence on the use of Zolgensma in a patient population older and heavier (1.5 – 9.1 years of age) than the children treated in previous clinical…
Pulse Update / Feb 16, 2024

Novartis appoints Sloan Simpson as Global Head of Investor Relations
Media Library / Feb 16, 2024

Novartis in Society Integrierter Geschäftsbericht 2023
Story / Feb 14, 2024

Listening to the CML patient community

Patient Perspectives

Improving the patient experience and removing potential barriers to clinical trial participation
Media Library / Feb 05, 2024

Novartis Radioligand Therapy (RLT) Manufacturing